NorthRock Partners, LLC
- SEC CIK
- 0001632097
- Latest filing
- Aug 11, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by NorthRock Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −1,943−100.0% | Sold out | Holders |
| Q3 2025 | 1,943 | $1.09M | <0.1% | +1,069+122.3% | Added | Holders |
| Q2 2025 | 874 | $458.9K | <0.1% | +166+23.4% | Added | Holders |
| Q1 2025 | 708 | $449.0K | <0.1% | −94−11.7% | Reduced | Holders |
| Q4 2024 | 802 | $571.3K | <0.1% | −156−16.3% | Reduced | Holders |
| Q3 2024 | 958 | $1.01M | <0.1% | +235+32.5% | Added | Holders |
| Q2 2024 | 723 | $759.9K | <0.1% | +64+9.7% | Added | Holders |
| Q1 2024 | 659 | $634.3K | <0.1% | +20+3.1% | Added | Holders |
| Q4 2023 | 639 | $561.2K | <0.1% | +390+156.6% | Added | Holders |
| Q3 2023 | 249 | $204.9K | <0.1% | +249 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −349−100.0% | Sold out | Holders |
| Q1 2023 | 349 | $286.8K | <0.1% | −17−4.6% | Reduced | Holders |
| Q4 2022 | 366 | $264.1K | <0.1% | +366 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −589−100.0% | Sold out | Holders |
| Q3 2021 | 589 | $356.0K | <0.1% | +589 | New | Holders |